Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Best Trial - Brazilian and Italian Evaluation of Safety Using Tacrolimus-eluting Stent With Short-term Dual Antiplatelet Regimen

NCT01122719 is registered in ClinicalTrials.gov with CID - Carbostent & Implantable Devices as lead sponsor.

NCT NCT01122719
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01122719 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Best Trial - Brazilian and Italian Evaluation of Safety Using Tacrolimus-eluting Stent With Short-term Dual Antiplatelet Regimen
Lead sponsor
CID - Carbostent & Implantable Devices
Phase
Not applicable
Overall status
Terminated
Start date
October 31, 2010
Completion date
March 31, 2013
Enrollment
16 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

documented silent ischemia, stable coronary disease, unstable coronary disease